Deutsche Bank Ag\ Ovid Therapeutics Inc. Transaction History

Deutsche Bank Ag\

$212 Billion
Q1 2024

A detailed history of Deutsche Bank Ag\ transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 23,981 shares of OVID stock, worth $17,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,981

Previous 22,884 4.79%

Holding current value

$17,985

Previous $73,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.72 - $4.04 $2,983 - $4,431	1,097 Added 4.79%	23,981 $73,000
Q4 2023 Feb 14, 2024	SELL	$2.98 - $3.78 $3,385 - $4,294	-1,136 Reduced 4.73%	22,884 $73,000
Q3 2023 Nov 09, 2023	BUY	$3.23 - $3.97 $77,584 - $95,359	24,020 New	24,020 $92,000
Q3 2021 Nov 04, 2021	SELL	$3.31 - $4.04 $283,223 - $345,686	-85,566 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$3.3 - $4.49 $176,596 - $240,277	53,514 Added 166.96%	85,566 $335,000

Q1 2021 May 13, 2021	SELL	$2.42 - $4.47 $1,064 - $1,966	-440 Reduced 1.35%	32,052 $128,000
Q4 2020 Feb 16, 2021	BUY	$2.28 - $6.84 $13,848 - $41,546	6,074 Added 22.99%	32,492 $75,000
Q3 2020 Nov 12, 2020	BUY	$5.39 - $8.24 $24,971 - $38,175	4,633 Added 21.27%	26,418 $152,000
Q2 2020 Aug 13, 2020	BUY	$2.67 - $7.91 $58,165 - $172,319	21,785 New	21,785 $160,000
Q1 2020 May 14, 2020	SELL	$2.03 - $4.35 $47,024 - $100,767	-23,165 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $26,823 - $65,253	12,896 Added 125.58%	23,165 $96,000
Q3 2019 Nov 14, 2019	BUY	$1.76 - $3.51 $12,210 - $24,352	6,938 Added 208.29%	10,269 $33,000
Q2 2019 Aug 14, 2019	SELL	$1.59 - $2.14 $403,750 - $543,412	-253,931 Reduced 98.71%	3,331 $6,000
Q1 2019 May 15, 2019	BUY	$1.77 - $3.56 $363,257 - $730,618	205,230 Added 394.43%	257,262 $454,000
Q4 2018 Feb 14, 2019	SELL	$2.42 - $6.6 $475,336 - $1.3 Million	-196,420 Reduced 79.06%	52,032 $125,000
Q3 2018 Dec 21, 2021	BUY	$5.6 - $11.0 $19,471 - $38,247	3,477 Added 1.42%	248,452 $1.41 Million
Q3 2018 Nov 14, 2018	SELL	$5.6 - $11.0 $337,388 - $662,728	-60,248 Reduced 19.74%	244,975 $1.39 Million
Q2 2018 Apr 21, 2020	BUY	$6.16 - $10.14 $25,878 - $42,598	4,201 Added 1.4%	305,223 $2.38 Million
Q2 2018 Aug 14, 2018	BUY	$6.16 - $10.14 $32,648 - $53,742	5,300 Added 1.79%	301,022 $2.35 Million
Q1 2018 Oct 18, 2019	BUY	$6.53 - $9.82 $18,852 - $28,350	2,887 Added 0.99%	295,722 $2.09 Million
Q1 2018 May 15, 2018	BUY	$6.53 - $9.82 $533,723 - $802,627	81,734 Added 38.72%	292,835 $2.07 Million
Q4 2017 Feb 14, 2018	BUY	$6.12 - $12.31 $40,434 - $81,332	6,607 Added 3.23%	211,101 $2.08 Million
Q3 2017 Nov 14, 2017	BUY	$5.32 - $9.77 $1.09 Million - $2 Million	204,494	204,494 $1.75 Million

Others Institutions Holding OVID

# of Institutions

Shares Held

43.2M

Call Options Held

5.9K

Put Options Held

300

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account